BP
BIIB icon

BNP Paribas’s Biogen BIIB Stock Holding History

BNP Paribas’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$941K Buy
4,360
+3,660
+523% +$700K 0.03% 167
2026
Q1 		$128K Hold
700
– – ﹤0.01% 240
2025
Q4 		$123K Sell
700
-104
-13% -$17K ﹤0.01% 256
2025
Q3 		$113K Hold
804
– – ﹤0.01% 237
2025
Q2 		$101K Sell
804
-70
-8% -$8.72K ﹤0.01% 248
2025
Q1 		$120K Buy
874
+70
+9% +$10K 0.01% 243
2024
Q4 		$123K Buy
804
+104
+15% +$17.5K ﹤0.01% 261
2024
Q3 		$136K Hold
700
– – 0.01% 244
2024
Q2 		$162K Hold
700
– – 0.01% 228
2024
Q1 		$151K Buy
+700
New +$164K 0.01% 240

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas's BIIB Position: Q2 2026 in Review

BNP Paribas increased its Biogen (BIIB) stake by 523% in Q2 2026, buying an estimated $700K and bringing the position to 4,360 shares worth $941K. The position accounts for 0.03% of the portfolio, ranked #167.

BNP Paribas first reported a position in BIIB in Q1 2024 and has held it in 10 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • BNP Paribas held 4,360 shares of Biogen worth $941K as of Q2 2026.
  • BNP Paribas bought 3,660 Biogen shares in Q2 2026, an estimated $700K.
  • Biogen made up 0.03% of BNP Paribas's portfolio in Q2 2026, its #167 holding.
  • BNP Paribas first reported a position in Biogen in Q1 2024 and has held it in 10 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.